Original Research

Accepted on 28 Nov 2023

Limosilactobacillus reuteri DSM 17938 and ATCC PTA 6475 for moderate to severe irritable bowel syndrome in adults: Randomized controlled trial

in Therapy in Gastroenterology

Sylvia Cruchet
Sandra Hirsch
Diana Villa-Lopez
Juan C. Palomo
Mucio Moreno-Portillo
Ana T. Abreu-Abreu
Juan M. Abdo-Francis
CARLOS JIMENEZ GUTIERREZ
Martin Rojano
Gabriel López-Velázquez

Frontiers in Gastroenterology

doi 10.3389/fgstr.2023.1296048

Review

Published on 07 Nov 2023

Current status and clinical applications of tissue engineering of the gastrointestinal tract: a systematized narrative review

in Therapy in Gastroenterology

Yilin Liu
Lynn Chong
Matthew Read

Frontiers in Gastroenterology

doi 10.3389/fgstr.2023.1277094

217 views

Original Research

Published on 23 Oct 2023

Adalimumab biosimilar ABP 501 is equally effective and safe in long-term management of inflammatory bowel diseases patients when used as first biologic treatment or as replace of the ADA originator for a non-medical reason

in Therapy in Gastroenterology

Giammarco Mocci
Arianna Cingolani
Giorgia Orrù
Carla Felice
Francesca Maria Onidi
Gianmarco Lombardi
Davide Checchin
Raffaele Colucci
Laurino Grossi
Antonio Ferronato

Frontiers in Gastroenterology

doi 10.3389/fgstr.2023.1218228

203 views

Original Research

Published on 18 Oct 2023

A blood-based transcriptomic signature stratifies severe Crohn’s disease and defines potentially targetable therapeutic pathways

in Therapy in Gastroenterology

Rivkah Gonsky
Evan Adams
Alka A. Potdar
Gregory Botwin
Eva Biener-Ramanujan
Dermot P. B. McGovern
Jonathan G. Braun
Phillip Fleshner
Stephan R. Targan

Frontiers in Gastroenterology

doi 10.3389/fgstr.2023.1251133

290 views

Review

Published on 03 Oct 2023

Sex- and gender-related differences in inflammatory bowel diseases

in Therapy in Gastroenterology

Irina Blumenstein
Elena Sonnenberg

Frontiers in Gastroenterology

doi 10.3389/fgstr.2023.1199687

528 views

Mini Review

Published on 09 Aug 2023

Molecular medicine-based IBD treatment strategies—we take it personally!

in Therapy in Gastroenterology

Viktoria Hentschel
Jochen Klaus

Frontiers in Gastroenterology

doi 10.3389/fgstr.2023.1226048

336 views

Brief Research Report

Published on 26 Jul 2023

A retrospective review of α-gal syndrome complicating the management of suspected pancreatic exocrine insufficiency in one gastroenterology clinic in central Virginia

in Therapy in Gastroenterology

Nathan E. Richards
Jeffrey M. Wilson
Thomas A. E. Platts-Mills
Robert D. Richards

Frontiers in Gastroenterology

doi 10.3389/fgstr.2023.1162109

888 views

Review

Published on 25 May 2023

Monitoring of patients with active inflammatory bowel disease

in Therapy in Gastroenterology

T. Kucharzik
B. Verstockt
C. Maaser

Frontiers in Gastroenterology

doi 10.3389/fgstr.2023.1172318

2,024 views

Systematic Review

Published on 01 May 2023

Preventing acute diverticulitis. any roles for non-absorbable antibiotics? in search of evidence: a systematic review, meta-analysis, and trial sequential analysis

in Therapy in Gastroenterology

Maurizio Koch
Alberto Enrico Maraolo
Giuseppe Natoli
Salvatore Corrao

Frontiers in Gastroenterology

doi 10.3389/fgstr.2023.1170271

886 views

Mini Review

Published on 23 Mar 2023

Fecal microbiota transfer to treat ulcerative colitis: Medical and legal challenges

in Therapy in Gastroenterology

Arndt Steube
Johannes Stallhofer
Andreas Stallmach

Frontiers in Gastroenterology

doi 10.3389/fgstr.2023.1161610

1,973 views

Systematic Review

Published on 09 Nov 2022

A systematic review and meta-analysis of Lactobacillus acidophilus and Lactobacillus bulgaricus for the treatment of diarrhea

in Therapy in Gastroenterology

Anthony Carona
David Jacobson
Charles F. Hildebolt
Waqar Qureshi
Kevin C. Rowland

Frontiers in Gastroenterology

doi 10.3389/fgstr.2022.983075

1,214 views

Review

Published on 17 Oct 2022

Innovative, complementary and alternative therapy in inflammatory bowel diseases: A broad 2020s update

in Therapy in Gastroenterology

Letizia Masi
Cristina Ciuffini
Valentina Petito
Laura Francesca Pisani
Loris Riccardo Lopetuso
Cristina Graziani
Daniela Pugliese
Lucrezia Laterza
Pierluigi Puca
Federica Di Vincenzo

Frontiers in Gastroenterology

doi 10.3389/fgstr.2022.1022530

1,974 views

Original Research

Published on 12 Oct 2022

Effect of calorie-restriction and rapamycin on autophagy and the severity of caerulein-induced experimental acute pancreatitis in mice

in Therapy in Gastroenterology

Manish Kumar Sharma
Kumari Priyam
Punit Kumar
Pramod Kumar Garg
Tara Sankar Roy
Tony George Jacob

Frontiers in Gastroenterology

doi 10.3389/fgstr.2022.977169

836 views
1 citation

Brief Research Report

Published on 23 Sep 2022

The α-Gal mammalian meat allergy as a cause of isolated gastrointestinal symptoms

in Therapy in Gastroenterology

Nathan E. Richards
Tom A. Makin
Anna R. Smith
Thomas A. E. Platts-Mills
Robert D. Richards
Jeffrey M. Wilson

Frontiers in Gastroenterology

doi 10.3389/fgstr.2022.987713

1,078 views
1 citation

Original Research

Published on 12 Aug 2022

To investigate the effects of artemisinin on inflammatory factors and intestinal microbiota in rats with ulcerative colitis based on network pharmacology

in Therapy in Gastroenterology

Yuxi Guo
Ze Li
Nan Cheng
Xuemei Jia
Jie Wang
Hongyu Ma
Runyuan Zhao
Bolin Li
Yanru Cai
Qian Yang

Frontiers in Gastroenterology

doi 10.3389/fgstr.2022.979314

807 views

Navigation group

Articles

Limosilactobacillus reuteri DSM 17938 and ATCC PTA 6475 for moderate to severe irritable bowel syndrome in adults: Randomized controlled trial

Current status and clinical applications of tissue engineering of the gastrointestinal tract: a systematized narrative review

Adalimumab biosimilar ABP 501 is equally effective and safe in long-term management of inflammatory bowel diseases patients when used as first biologic treatment or as replace of the ADA originator for a non-medical reason

A blood-based transcriptomic signature stratifies severe Crohn’s disease and defines potentially targetable therapeutic pathways

Sex- and gender-related differences in inflammatory bowel diseases

Molecular medicine-based IBD treatment strategies—we take it personally!

A retrospective review of α-gal syndrome complicating the management of suspected pancreatic exocrine insufficiency in one gastroenterology clinic in central Virginia

Monitoring of patients with active inflammatory bowel disease

Preventing acute diverticulitis. any roles for non-absorbable antibiotics? in search of evidence: a systematic review, meta-analysis, and trial sequential analysis

Fecal microbiota transfer to treat ulcerative colitis: Medical and legal challenges

A systematic review and meta-analysis of Lactobacillus acidophilus and Lactobacillus bulgaricus for the treatment of diarrhea

Innovative, complementary and alternative therapy in inflammatory bowel diseases: A broad 2020s update

Effect of calorie-restriction and rapamycin on autophagy and the severity of caerulein-induced experimental acute pancreatitis in mice

The α-Gal mammalian meat allergy as a cause of isolated gastrointestinal symptoms

To investigate the effects of artemisinin on inflammatory factors and intestinal microbiota in rats with ulcerative colitis based on network pharmacology